The Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of Quantitative Polymerase Chain Reaction (qPCR) instruments has seen a rapid expansion in recent years. The market, valued at $1.51 billion in 2024, is forecasted to reach $1.66 billion in 2025, reflecting a Compound Annual Growth Rate (CAGR) of 10.4%.
The Quantitative Polymerase Chain Reaction (qPCR) instruments market is forecasted to reach a value of $2.45 billion by the year 2029. This represents a compound annual growth rate (CAGR) of 10.2% during the forecast per
Download Your Free Sample of the 2025 Quantitative Polymerase Chain Reaction (qPCR) Instruments Market Report and Uncover Key Trends Now!The key drivers in the quantitative polymerase chain reaction (qpcr) instruments market are:
• The rise in global cases of infectious diseases
• Increased global travel facilitating rapid spread of pathogens
• The ability of qPCR instruments to rapidly detect pathogens
• Emergence of qPCR instruments for timely diagnosis and disease management
The quantitative polymerase chain reaction (qpcr) instruments market covered in this report is segmented –
1) By Product Type: Quantitative Polymerase Chain Reaction Systems, Reagents And Consumables, Software
2) By Instrument: 7500, Viia 7 Dx, Cobas 4800, Cfx96, Smartcycler, Genexpert, Rotor-Gene Q, Rotor-Gene Q 5plex Hrm System, Biofire Filmarray Systems, Other Instruments
3) By Application: Gene Expression, Genotyping, Pathogen Detection, Diagnostics, Other Applications
4) By End-Users: Diagnostic Laboratories, Hospitals And Clinics, Pharma And Biotech Companies, Other End-Users
The key trends in the quantitative polymerase chain reaction (qpcr) instruments market are:
• Development of innovative solutions such as next-generation qPCR platforms by major companies is an emerging trend.
• These innovative platforms aim to enhance testing accuracy and efficiency, and enable a competitive position in the diagnostics sector.
• The new qPCR systems promise superior sensitivity, swift processing, expanded multiplexing and advanced automation for better testing performance and precision.
• The next-generation platforms also offer improved workflows, simplified data handling, and an enhanced user interface for easier system integration.
Major players in the quantitative polymerase chain reaction (qpcr) instruments market are:
• F. Hoffmann-La Roche AG.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Becton, Dickinson and Company
• Agilent Technologies Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Eppendorf SE
• Cepheid Inc.
• Takara Bio Inc.
• bioMérieux SA
• Analytik Jena GmbH
• Standard BioTools Inc.
• Hangzhou Bioer Technology Co. Ltd.
• BioTeke Corporation
• GeneReach Biotechnology Corp.
• Anitoa Systems LLC
• Blue-Ray Biotech Corp.
• Chai Biotechnologies
• Bio Molecular Systems Pty Ltd.
• Azure Biosystems Inc.
North America was the largest region in the quantitative polymerase chain reaction (qPCR) instruments market in 2024